Company: BDRX
Filing Date: 2025-01-28
Form Type: 424B3
Source: 0001214659-25-001409
Chunk: 360

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-28
Form: 424B3
Chunk 360
---
2021 £’000 |   |
| Issued capital and reserves attributable to owners of the parent |     |      |     |            |   |     |            |   |     |            |   |
| Share capital                                                    |     |   21 |     |      6,253 |   |     |      1,108 |   |     |      1,098 |   |
| Share premium                                                    |     |   22 |     |     86,732 |   |     |     83,667 |   |     |     83,434 |   |
| Merger reserve                                                   |     |   22 |     |     53,003 |   |     |     53,003 |   |     |     53,003 |   |
| Warrant reserve                                                  |     |   22 |     |      3,457 |   |     |        720 |   |     |        720 |   |
| Accumulated deficit                                              |     |   22 |     |   (144,767 | ) |     |   (135,336 | ) |     |   (127,803 | ) |
| Total equity                                                     |     |      |     |      4,678 |   |     |      3,162 |   |     |     10,452 |   |
| Total equity and liabilities                                     |     |      |     |     10,542 |   |     |      5,525 |   |     |     12,913 |   |

The notes form an integral
part of these consolidated financial statements.

| F-25 |

Consolidated
statements of cash flows

For the year ended 31 December

|                                                                        |     | Note |     | 2023 £’000 |   |     | 2022 £’000 |   |     | 2021 £’000 |   |
| Cash flows from operating activities                                   |     |      |     |            |   |     |            |   |     |            |   |
| Loss for the year                                                      |     |      |     |     (7,079 | ) |     |     (7,656 | ) |     |     (5,460 | ) |
| Adjustments for:                                                       |     |      |     |            |   |     |            |   |     |            |   |
| Depreciation of property, plant and equipment